XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating Activities    
Net income (loss) $ 3,789 $ (17,047)
Adjustments to reconcile net income (loss) to operating activities:    
Amortization, depreciation and write-offs 195,973 83,704
Amortization of debt issuance costs and discount 6,380 3,414
Stock-based compensation 57,103 8,494
Change in operating right-of-use asset 12,267 3,578
Lease modification and abandonment of leasehold improvements 0 7,851
Loss on settlement of debt 16,852 0
Net unrealized gains on fair value remeasurement of financial instruments (9,855) (2,940)
Net gain on foreign currency remeasurement 952 203
Changes in operating assets and liabilities:    
Accounts receivable (69,881) 7,708
Prepaid expenses and other current assets (92,851) (16,840)
Other assets 5,269 2,598
Accounts payable 33,936 (5,713)
Operating lease liabilities (12,083) (2,828)
Accrued and other liabilities 6,752 (2,839)
Deferred revenue (2,327) 15,915
Net cash provided by operating activities 152,276 85,258
Investing Activities    
Purchase of property and equipment (653) (1,183)
Acquisitions, net of cash acquired (1,017,012) (523,202)
Purchase of non-marketable investments and other (14,000) 0
Proceeds from other investing activities 10,000 0
Capitalized software development costs (1,517) 0
Net cash used in investing activities (1,023,182) (524,385)
Financing Activities    
Proceeds from issuance of common stock in initial public offering, net of issuance costs as adjusted for cost reimbursement 1,744,240 0
Proceeds from debt issuance, net of issuance costs 844,729 331,346
Payments of debt principal (706,905) (56,690)
Payments of finance leases (4,621) (4,356)
Proceeds from exercise of stock options 17,888 262
Payments of deferred acquisition costs (157,565) (11,020)
Repurchases of common stock 0 (1,766)
Net cash provided by financing activities 1,737,766 257,776
Effect of foreign exchange rate on cash and cash equivalents (352) 9
Net increase (decrease) in cash and cash equivalents 866,508 (181,342)
Cash and cash equivalents at beginning of the period 317,235 396,247
Cash and cash equivalents at end of the period 1,183,743 214,905
Supplemental non-cash investing and financing activities disclosures:    
Issuance of convertible security related to acquisitions 342,170 0
Acquisitions of business through issuance of common stock and common stock warrants 0 38,167
Acquisitions not yet paid 119,256 9,169
Deferred IPO costs not yet paid 986 0
Assets acquired under finance leases 2,658 2,780
Right of use assets acquired under operating leases 0 6,937
Supplemental disclosure of cash flow information:    
Cash paid for interest on debt 31,767 30,236
Cash paid for income taxes $ 32,737 $ 1,866